SCHEMBL3096992

SCHEMBL3096992

O=C1C[C@H](C(=O)Nc2ccc(-n3ccccc3=O)cc2)N(C(=O)O)C1

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F10 P00742 18/20 0.47
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3097010 1.00 F10 (0.47) F10LMNAPKM
SCHEMBL76295 0.85 HDAC8 (0.48) F10
SCHEMBL6012176 0.77 F10 (0.44) F10
SCHEMBL13626553 0.76 F10 (0.61) F10
SCHEMBL13626552 0.76 F10 (0.61) F10
SCHEMBL13626565 0.76 F10 (0.56) F10LMNAPKM
SCHEMBL4604696 0.73 F10 (0.69) F10
SCHEMBL13626567 0.71 F10 (0.52) F10LMNAPKM
SCHEMBL13909447 0.71 NPC1 (0.66) LMNA
SCHEMBL76384 0.70 F10 (0.56) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906516-B2 Carbonyl compounds MERCK PATENT GMBH (DE) 2011-03-15 US disclosed
US-20100256131-A1 CARBONYL COMPOUNDS TSAKLAKIDIS CHRISTOS 2010-10-07 US disclosed
US-20080003214-A1 Medicaments Comprising Carbonyl Compounds, And The Use Thereof MERCK PATENT GMBH (DE) 2008-01-03 US disclosed
US-20060183739-A1 Carbonyl compounds MERCK PATENT GMBH (DE) 2006-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256131-A1 CARBONYL COMPOUNDS F2, F11, PDHX F10 5/4885LMNA 918/4885PKM 728/4885
US-20080003214-A1 Medicaments Comprising Carbonyl Compounds, And The Use Thereof F2, PDHX, SDHB F10 22/4885LMNA 626/4885PKM 1047/4885
US-20060183739-A1 Carbonyl compounds F2, F11, PDHX F10 5/4885LMNA 918/4885PKM 728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.